Overview

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors

Status:
Withdrawn
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The primary goals of hyperthermia combined with chemotherapy/radiotherapy on treatment failure solid tumors are tumor response rate, while secondary goals are rates of acute and late adverse effects, local control rate, distant metastasis rate, progression-free rate and overall survival rate.
Phase:
Phase 2
Details
Lead Sponsor:
Shin Kong Wu Ho-Su Memorial Hospital
Treatments:
Cisplatin
Docetaxel